Literature DB >> 20094814

Impact of postoperative pancreatic fistula on surgical outcome--the need for a classification-driven risk management.

Andreas Schmid Frymerman1, Jochen Schuld, Patrick Ziehen, Otto Kollmar, Christoph Justinger, Marco Merai, Sven Richter, Martin Karl Schilling, Mohammed Reza Moussavian.   

Abstract

BACKGROUND: The International Study Group of Pancreatic Fistula (ISGPF) classification allows comparison of incidence and severity of postoperative pancreatic fistula (POPF). Its post hoc character, however, does not provide a guideline for the treatment of POPF in individual patient. We therefore studied the association of POPF type A-C on secondary surgical morbidity and mortality in patients undergoing pancreatic resection. PATIENTS AND METHODS: Between 3/2001-12/2007, 483 patients underwent pancreatic resections. POPF were classified according to the ISGPF classification. All patient data were entered in a clinical data management system prospectively.
RESULTS: Patients who developed POPF had significantly more vascular but not other surgical complications than patients without POPF. Patients with POPF A had no vascular or surgical complications. Twenty one of the 29 patients with POPF C had surgical complications (17 vascular complications). Mortality attributed to surgical complications after POPF C was 5/29. A soft pancreatic consistency (OR 8.5; p < 0.008) and a high drain lipase activity on postoperative day 3 (OR 4.4; p = 0,065) were predictors for the development of POPF C. DISCUSSION: POPF C is associated with vascular complications like erosion bleeding and other surgical complications like delayed gastric emptying or pleural effusions. A soft pancreatic consistency and a high drain lipase activity on postoperative day 3 are early predictors for the development of POPF C.

Entities:  

Mesh:

Year:  2010        PMID: 20094814     DOI: 10.1007/s11605-009-1147-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  16 in total

1.  Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials.

Authors:  Qiqiang Zeng; Qiyu Zhang; Shaoliang Han; Zhengping Yu; Minghua Zheng; Mengtao Zhou; Jianling Bai; Rong Jin
Journal:  Pancreas       Date:  2008-01       Impact factor: 3.327

Review 2.  Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection.

Authors:  Antonio Ramos-De la Medina; Michael G Sarr
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006

3.  Risk prediction for development of pancreatic fistula using the ISGPF classification scheme.

Authors:  Wande B Pratt; Mark P Callery; Charles M Vollmer
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

4.  Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections.

Authors:  Emre F Yekebas; Lars Wolfram; Guellue Cataldegirmen; Christian R Habermann; Dean Bogoevski; Alexandra M Koenig; Jussuf Kaifi; Paulus G Schurr; Michael Bubenheim; Claus Nolte-Ernsting; Gerhard Adam; Jakob R Izbicki
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

5.  Pancreatojejunal leakage after pancreas head resection: anatomic and surgeon-related factors.

Authors:  O Kollmar; M R Moussavian; M Bolli; S Richter; M K Schilling
Journal:  J Gastrointest Surg       Date:  2007-09-02       Impact factor: 3.452

6.  [Influence of IT-supported clinical pathways on patient satisfaction at a surgical department of a university hospital].

Authors:  J Schuld; S Richter; J Folz; P Jacob; S Gräber; M K Schilling
Journal:  Dtsch Med Wochenschr       Date:  2008-06       Impact factor: 0.628

Review 7.  The challenge of pancreatic anastomosis.

Authors:  Axel Kleespies; Markus Albertsmeier; Firas Obeidat; Hendrik Seeliger; Karl-Walter Jauch; Christiane J Bruns
Journal:  Langenbecks Arch Surg       Date:  2008-04-01       Impact factor: 3.445

8.  Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Shigeki Kusamura; Dario Baratti; Adelmo Antonucci; Rami Younan; Barbara Laterza; Grazia Daniela Oliva; Cecilia Gavazzi; Marcello Deraco
Journal:  Ann Surg Oncol       Date:  2007-10-02       Impact factor: 5.344

9.  Fatty pancreas: a factor in postoperative pancreatic fistula.

Authors:  Abhishek Mathur; Henry A Pitt; Megan Marine; Romil Saxena; C Max Schmidt; Thomas J Howard; Attila Nakeeb; Nicholas J Zyromski; Keith D Lillemoe
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

10.  Clinical pathways in general surgery. Development, implementation, and evaluation.

Authors:  S Graeber; S Richter; J Folz; P-T Pham; P Jacob; M K Schilling
Journal:  Methods Inf Med       Date:  2007       Impact factor: 2.176

View more
  18 in total

1.  The need of a severity scoring system for postoperative pancreatic fistulas.

Authors:  Sergio Pedrazzoli; Alen Silvio Canton; Cosimo Sperti
Journal:  J Gastrointest Surg       Date:  2010-06-30       Impact factor: 3.452

2.  Evaluation of postoperative pancreatic fistula after total gastrectomy with D2 lymphadenectomy by ISGPF classification.

Authors:  Yuichiro Miki; Masanori Tokunaga; Etsuro Bando; Yutaka Tanizawa; Taiichi Kawamura; Masanori Terashima
Journal:  J Gastrointest Surg       Date:  2011-08-11       Impact factor: 3.452

3.  Drain amylase value as an early predictor of pancreatic fistula after cephalic duodenopancreatectomy.

Authors:  Vladimir D Dugalic; Djordje M Knezevic; Vladan N Obradovic; Miroslava G Gojnic-Dugalic; Slavko V Matic; Aleksandra R Pavlovic-Markovic; Predrag D Dugalic; Srbislav M Knezevic
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

4.  Prediction of Pancreatic Fistula After Distal Pancreatectomy Based on Cross-Sectional Images.

Authors:  Ye Rim Chang; Jae Seung Kang; Jin-Young Jang; Woo Hyun Jung; Mee Joo Kang; Kyung Bun Lee; Sun-Whe Kim
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

5.  Risk Factors and Management of Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy: Single-center Experience.

Authors:  Zun-Xiang Ke; Jiong-Xin Xiong; Jin Hu; Heng-Yu Chen; Qin Li; Yi-Qing Li
Journal:  Curr Med Sci       Date:  2019-12-16

6.  Defining treatment and outcomes of hepaticojejunostomy failure following pancreaticoduodenectomy.

Authors:  Richard A Burkhart; Daniel Relles; Danielle M Pineda; Salil Gabale; Patricia K Sauter; Ernest L Rosato; Leonidas G Koniaris; Harish Lavu; Eugene P Kennedy; Charles J Yeo; Jordan M Winter
Journal:  J Gastrointest Surg       Date:  2013-01-05       Impact factor: 3.452

7.  Neoadjuvant Radiation Is Associated with Fistula Formation Following Pancreaticoduodenectomy.

Authors:  Sara L Zettervall; Tammy Ju; Jeremy L Holzmacher; Lisbi Rivas; Paul P Lin; Khashayar Vaziri
Journal:  J Gastrointest Surg       Date:  2018-03-02       Impact factor: 3.452

8.  Clinical validation of the ISGPF classification and the risk factors of pancreatic fistula formation following duct-to-mucosa pancreaticojejunostomy by one surgeon at a single center.

Authors:  Woo Seok Kim; Dong Wook Choi; Seong Ho Choi; Jin Seok Heo; Min Jung Kim; Sun Choon Song; Hyung Geun Lee; Dong Do You
Journal:  J Gastrointest Surg       Date:  2011-10-15       Impact factor: 3.452

9.  Pancreatic anastomotic leakage after pancreaticoduodenectomy. Risk factors, clinical predictors, and management (single center experience).

Authors:  Ayman El Nakeeb; Tarek Salah; Ahmad Sultan; Mohamed El Hemaly; Waleed Askr; Helmy Ezzat; Emad Hamdy; Ehab Atef; Ehab El Hanafy; Ahmed El-Geidie; Mohamed Abdel Wahab; Talaat Abdallah
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

Review 10.  Systematic review and meta-analysis of fibrin sealants for patients undergoing pancreatic resection.

Authors:  Lorenzo A Orci; Graziano Oldani; Thierry Berney; Axel Andres; Gilles Mentha; Philippe Morel; Christian Toso
Journal:  HPB (Oxford)       Date:  2013-03-06       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.